These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25224512)

  • 1. Controversial therapeutics: the β-adrenergic antagonist and cocaine-associated cardiovascular complications dilemma.
    Schurr JW; Gitman B; Belchikov Y
    Pharmacotherapy; 2014 Dec; 34(12):1269-81. PubMed ID: 25224512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Blockers, Cocaine, and the Unopposed α-Stimulation Phenomenon.
    Richards JR; Hollander JE; Ramoska EA; Fareed FN; Sand IC; Izquierdo Gómez MM; Lange RA
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):239-249. PubMed ID: 28399647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of in-hospital outcomes for beta-blocker use versus non-beta blocker use in patients presenting with cocaine-associated chest pain.
    Fanari Z; Kennedy KK; Lim MJ; Laddu AA; Stolker JM
    Am J Cardiol; 2014 Jun; 113(11):1802-6. PubMed ID: 24742472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Death temporally related to the use of a Beta adrenergic receptor antagonist in cocaine associated myocardial infarction.
    Fareed FN; Chan G; Hoffman RS
    J Med Toxicol; 2007 Dec; 3(4):169-72. PubMed ID: 18072171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying patients with cocaine-related chest pain at true risk for beta-blocker toxicity.
    Canning J; Brooks DE; Gerkin RD
    Arch Intern Med; 2010 Nov; 170(20):1859; author reply 1860. PubMed ID: 21059983
    [No Abstract]   [Full Text] [Related]  

  • 6. Cocaine-induced chest pain and beta-blockade: an inner city experience.
    Mohamad T; Kondur A; Vaitkevicius P; Bachour K; Thatai D; Afonso L
    Am J Ther; 2008; 15(6):531-5. PubMed ID: 19127137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular consequences of cocaine use.
    Stankowski RV; Kloner RA; Rezkalla SH
    Trends Cardiovasc Med; 2015 Aug; 25(6):517-26. PubMed ID: 25657055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should beta-blockers be used in the treatment of cocaine-associated acute coronary syndrome?
    Page RL; Utz KJ; Wolfel EE
    Ann Pharmacother; 2007 Dec; 41(12):2008-13. PubMed ID: 17956961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockers for chest pain associated with recent cocaine use.
    Rangel C; Shu RG; Lazar LD; Vittinghoff E; Hsue PY; Marcus GM
    Arch Intern Med; 2010 May; 170(10):874-9. PubMed ID: 20498415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of β-blockers in the acute management of cocaine-associated chest pain.
    Ibrahim M; Maselli DJ; Hasan R; Hamilton A
    Am J Emerg Med; 2013 Mar; 31(3):613-6. PubMed ID: 23122421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options.
    Phillips K; Luk A; Soor GS; Abraham JR; Leong S; Butany J
    Am J Cardiovasc Drugs; 2009; 9(3):177-96. PubMed ID: 19463023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theodore E. Woodward award: cardiovascular complications of cocaine abuse.
    Lange RA; Cigarroa JE; Hillis LD
    Trans Am Clin Climatol Assoc; 2004; 115():99-111; discussion 112-4. PubMed ID: 17060960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocaine-induced myocardial ischemia and infarction: pathophysiology, recognition, and management.
    Pitts WR; Lange RA; Cigarroa JE; Hillis LD
    Prog Cardiovasc Dis; 1997; 40(1):65-76. PubMed ID: 9247556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics, management, and outcomes of cocaine-positive patients with acute coronary syndrome (from the National Cardiovascular Data Registry).
    Gupta N; Washam JB; Mountantonakis SE; Li S; Roe MT; de Lemos JA; Arora R
    Am J Cardiol; 2014 Mar; 113(5):749-56. PubMed ID: 24388623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine and beta-blockers: the paradigm.
    Damodaran S
    Eur J Intern Med; 2010 Apr; 21(2):84-6. PubMed ID: 20206876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual cocaine and methamphetamine cardiovascular toxicity: rapid resolution with labetalol.
    Richards JR; Lange RA; Arnold TC; Horowitz BZ
    Am J Emerg Med; 2017 Mar; 35(3):519.e1-519.e4. PubMed ID: 27707569
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-blockers are associated with reduced risk of myocardial infarction after cocaine use.
    Dattilo PB; Hailpern SM; Fearon K; Sohal D; Nordin C
    Ann Emerg Med; 2008 Feb; 51(2):117-25. PubMed ID: 17583376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine and cardiovascular complications.
    Bhargava S; Arora RR
    Am J Ther; 2011 Jul; 18(4):e95-e100. PubMed ID: 21150772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the use of beta-blockers in COPD still an unresolved dilemma?
    Foresi A; Cavigioli G; Signorelli G; Pozzoni MB; Olivieri D
    Respiration; 2010; 80(3):177-87. PubMed ID: 20639691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a brief observation period for patients with cocaine-associated chest pain.
    Weber JE; Shofer FS; Larkin GL; Kalaria AS; Hollander JE
    N Engl J Med; 2003 Feb; 348(6):510-7. PubMed ID: 12571258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.